177lu-psma-617,olaparib
novartis,merck,astrazeneca
['luparp', 'lu177', 'prostate', 'olaparib']
the luparp study evaluating the combination of olaparib with lu177 showing promising activity. #prostatecancer #asco23 
Medical Oncologist at @UFHealthCancer and Assistant Professor of Medicine at @UF